Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "Dermatologic Therapy"
DOI: 10.1111/dth.12846
Abstract: Real-life data on the effectiveness and safety of biosimilar and biologic drugs licensed for treatment of psoriasis is lacking. We retrospectively analysed patient records from 69 patients with moderate to severe psoriasis treated at the… read more here.
Keywords: effectiveness safety; biosimilar infliximab; safety; infliximab etanercept ... See more keywords
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0241575
Abstract: Psoriasis is an inflammatory and chronic skin disorder associated with physical and psychological burden impairing patients’ quality of life. In the last decade, biologic drugs have widely changed treatment of moderate-severe psoriasis and their number… read more here.
Keywords: biologic drugs; infliximab etanercept; pharmacovigilance; adverse events ... See more keywords